7 The composition containing combination of 7 probiotics which have efficacy preventing from insulin resistance which cause type 2 diabetes mellitus as a effector component
The present invention Bifidobacterium ronggeom (Bifidobacterium longum) HY8005, Bifidobacterium Infante Tees (Bifidobacterium infantis) HY8401, Bifidobacterium lactis (Bifidobacterium lactis) HY8101, Bifidobacterium breve (Bifidobacterium breve) HY8201, The present invention relates to a composition comprising seven kinds of lactic acid bacterial strain having an insulin resistance improving effect consisting of Lactobacillus gasseri HY7023, Lactobacillus acidophilus HY7037 and Lactobacillus casei HY7212 as active ingredients A food composition, a fermented milk, a beverage, a health functional food, and the like, which have an effect of preventing or improving diabetes through improvement of insulin resistance.본 발명은 비피도박테리움 롱검(Bifidobacterium longum) HY8005, 비피도박테리움 인판티스(Bifidobacterium infantis) HY8401, 비피도박테리움 락티스(Bifidobacterium lactis) HY8101, 비피도박테리움 브레베(Bifidobacterium breve) HY8201, 락토바실러스 가세리(Lactobacillus gasseri) HY7023, 락토바실러스 애시도필러스(Lactobacillus acidophilus) HY7037 및 락토바실러스 카제이(Lactobacillus casei) HY7212로 이루어진 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물에 관한 것으로서 인슐린 저항성 개선을 통한 당뇨병의 예방 또는 개선 효과를 갖는 약학 조성물, 식품조성물, 발효유, 음료, 건강기능식품 등 다양하게 응용될 수 있다.
